Oxygen-ozone Therapy Plus Antibiotic Therapy in the Treatment of Infections Secondary to Implant of Orthopaedic Devices - Trial NCT04787575
Access comprehensive clinical trial information for NCT04787575 through Pure Global AI's free database. This phase not specified trial is sponsored by Società Scientifica Internazionale di Ossigeno Ozono Terapia and is currently Not yet recruiting. The study focuses on Infection. Target enrollment is 186 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Società Scientifica Internazionale di Ossigeno Ozono Terapia
Timeline & Enrollment
N/A
Jun 01, 2021
Sep 01, 2022
Primary Outcome
Clinical success at Day 14
Summary
This is an open-label, multicentre, randomized, parallel group study to evaluate the efficacy
 of treatment with oxygen-ozone therapy plus oral antibiotic therapy, in comparison with oral
 antibiotic therapy alone, in the proportion of patients with resolution/improvement of signs
 and symptoms of infection of the wound (e.g. ulcer, eschar, sore) in the target lesion after
 14 days of treatment, in patients with infections secondary to implant of orthopaedic
 devices.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04787575
Non-Device Trial